ADPKD
|
Autosomal Dominant Polycystic Kidney Disease |
ADR
|
Adriamycin |
AKI
|
Acute kidney injury |
APC
|
Adenomatous polyposis coli |
AQP1
|
Aquaporin-1 |
ARPKD
|
Autosomal Recessive Polycystic Kidney Disease |
AXIN
|
Axis inhibitor |
CK
|
Casein kinase |
CKD
|
Chronic Kidney Disease |
DKK
|
Dickkopf |
DN
|
Diabetic nephropathy |
Dvl
|
Dishevelled |
E
|
Embryonic day |
ESRD
|
End-stage renal disease |
FSGS
|
Focal and segmental glomerulosclerosis |
Fz
|
Frizzled |
GFR
|
Glomerular Filtration Rate |
GSK
|
Glycogen synthase kinase |
HEK293
|
Human embryonic kidney 293 cells |
IgAN
|
IgA nephropathy |
Inv
|
Inversin |
IRI
|
Ischaemia reperfusion injury |
Jbn
|
Jouberin |
JS
|
Joubert syndrome |
JSRD
|
Joubert syndrome and related disorders |
KO
|
Knockout |
LOF
|
Loss of function |
Lp
|
Loop-tail |
LRP
|
Lipoprotein receptor related protein |
MDCK
|
Madin-Darby Canine Kidney |
MEF
|
Mouse embryonic fibroblast |
MGS |
Meckel-Gruber Syndrome |
MM
|
Metanephric mesenchyme |
MMP-7
|
Matrix metalloproteinase-7 |
NPHP
|
Nephronophthisis |
PAI-1
|
Plasminogen activator inhibitor-1 |
PC
|
Polycystin |
PCP
|
Planar Cell Polarity |
PKD
|
Polycystic Kidney Disease |
PKHD1
|
Polycystic Kidney and Hepatic Disease 1 |
sFRP
|
Soluble Frizzled-related protein |
TRPC
|
Transient receptor potential cation channel |
UUO
|
Unilateral Ureteral Obstruction |